Skip to main content
Clinical Trials/CTRI/2024/04/066155
CTRI/2024/04/066155
Not yet recruiting
Phase 4

A comparative study on efficacy of intralesional methotrexate vs intralesional triamcinolone acetonide in chronic plaque psoriasis - NI

Sampath V0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: L400- Psoriasis vulgaris
Sponsor
Sampath V
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Sampath V

Eligibility Criteria

Inclusion Criteria

  • 1\)All patients with clinical features of chronic Plaque psoriasis with less than 5 Plaques
  • 2\)Patients who have given consent for the study and are willing to come for regular follow up at the psoriasis clinic.
  • 3\)Patients who had not been on any systemic and topical anti psoriatic medications for at least the past 2 months will be enrolled.

Exclusion Criteria

  • 1\)Patients with unstable psoriasis
  • 2\)Pregnant and Lactating Women
  • 3\)Patients of Psoriasis vulgaris with history of Hypersensitivity to MTX or Triamcinolone.
  • 4\)Patients with bleeding disorders and on anti\-coagulant therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials